Systems And Methods For Facilitating Diagnosis, Prognosis And Treatment Of Cancer Based On Detection Of Her3 Activation

  • Published: Jan 20, 2016
  • Earliest Priority: Apr 05 2013
  • Family: 8
  • Cited Works: 1
  • Cited by: 0
  • Cites: 6
  • Additional Info: Cited Works

The full document isn't yet available to us from the patent office, but we've found a related patent (family member) to use for our images and PDF.


Systems and methods are provided for facilitating diagnosis, prognosis and treatment of cancer based on detection of HER3 activation. The systems and methods involve analysis of samples for the presence or the absence of activated HER3 markers as indicated by HER2-HER3 heterodimers, HER3 phosphorylation, or recruitment of PI3K to activated HER3 (HER3/PI3K complexes). The amounts of activated HER3 marker expression may be measured alone or in conjunction with other biomarkers.


Information currently unavailable.

Family Member PDF
Family Member Preview
These are the images from a related family member, as the full document isn't yet available to us from the patent office.
Document History
  • Publication: Jan 20, 2016
  • Application: Apr 7, 2014
    CN CN 201480030240 A
  • Priority: Apr 7, 2014
    US US 2014/0033208 W
  • Priority: Apr 5, 2013
    US US 201361809083 P

Download Citation

Sign in to the Lens